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A NUMBER of tumors of experimental animals and of man are strongly inhibi-
ted in vivo by certain l-asparaginases (Broome, 1961, 1963, 1965, 1968a; Mashburn
and Wriston, 1964). However, preparations ofthe enzyme from different sources
vary greatly in tumor inhibitory activity. In previous work we have demonstrated
2 factors which may determine this: first, the rate of removal of the asparaginase
from the blood of treated animals, and secondly the avidity of the enzyme for
asparagine (Broome, 1965; Schwartz, Reeves and Broome, 1966). Thus, yeast
asparaginase which almost completely disappeared from mouse blood within 30
minutes ofinjection, failed to inhibit tumors, while guinea-pig serum asparaginase
with a half-life in the blood of 11 to 19 hours, was highly effective (Broome, 1965).
This explanation cannot, however, account for observations with the inducible
asparaginase of E. coli, for it is normally cleared from the blood with a half-life
which varies in different preparations from 55 minutes to 3 hours. Yet this
enzyme, when tested either 1 day after tumor implantation or when palpable
tumors are present, produces a greater tumor inhibition in relation to conventional
in vitro enzyme assays than serum asparaginase of the guinea-pig or agouti
(Schwartz, Reeves and Broome, 1966; Mashburn et al., 1967). Its effectiveness
in vivo has been related to a particularly high avidity for asparagine (Schwartz,
Reeves and Broome, 1966).
The purpose of the present paper is to show in further detail the relationship
between the tumor inhibitory activities and in vitro enzyme kinet.ics of aspara-
ginases from E. coli and a agouti serum, and in addition to show how certain other
properties ofthe E. coli asparaginase which prolong its action in vivo may augment
its ability to inhibit tumors.
MATERIALS AND METHODS
Asparaginase.-Agouti serum asparaginase was obtained as described earlier
(Broome, 1968b). E. coli asparaginase was generously provided by the Worthing-
ton Biochemical Company, Freehold, New Jersey, and the National Cancer
Institute for which it was prepared by the Squibb Institute (Dr. Bernard Berk).
In both cases the method ofpreparation is basically that ofMashburn and Wriston
(1964). Although the initial bacterial extracts contain two asparaginases, final
preparations contain only the high avidity inducible enzyme (Schwartz, Reeves
and Broome, 1966). Preparations used had specific activities of 2050 and 4150
units per mg. ofprotein.
Asparaginase assays.-Assays of enzyme in blood and plasma have been made
at high substrate concentration (5 x 10-3 M) as in earlier reports (Broome, 1963,J. D. BROOME
1965). In other experiments a technique measuring the conversion of 14C
asparagine to aspartic acid has been employed. Incubation mixtures consist
of 1a8 X 10 2M sodium borate, 4-6 x 10 2M sodium chloride, 2O x 1 3M
potassium chloride and 8-0 x 10-4 M calcium chloride (pH 7.7) and known
concentrations of asparagine (5 x 10-3 to 2 x 10-6 M) with a quantity of 14C
label, usually 0-2 ,uCi/ml. (1-asparagine-_4C, uniformly labelled, Nuclear Chicago,
Des Plains, Ill). Enzyme is incubated with this for 7-60 minutes when the
reaction is stopped and protein coagulated by heating in a boiling waterbath for
2 minutes. The supernatant is spotted on 3 MM Whatman paper and subjected
to high voltage electrophoresis in 4 x 10-2 M phosphate buffer (pH 6.4) at 50
v/cm. for 30 minutes, using a 30-inch flat plate apparatus (Savant Instruments,
Inc., Hicksville, N.Y.). After the paper is dried an autoradiogram on Kodak
RB-54 film is made (24-48 hours exposure), which is used to locate aspartate
and asparagine. Areas of paper 1- inch x 1 inch containing the amino acids
are then cut out. These are counted by liquid scintillation in toluene PPO-
POPOP (Liquifluor New England Nuclear, Boston). From measurements of
the proportion of asparagine converted to aspartate, rates of hydrolysis can
readily be calculated. The unit of asparaginase activity is that which hydrolyses
1 It mole asparagine in 1 hour.
Blood asparagine levels. Methods for measurement are described elsewhere
(Broome, 1966, 1968b).
Mice and tumors.-C3H or C3H/C57B1 F1 (Microbiological Associates, Beth-
esda, Maryland) weighing 20-25 g. have been used. Methods of implanting
Lymphoma 6C3HED and its asparaginase-resistant sublines have been those
described earlier (Broome, 1963; Schwartz, Reeves and Broome, 1966).
EXPERIMENTAL RESULTS
Kinetics of agouti serum and E. coli asparaginases.
The conventional asparagine concentrations at which asparaginase assays
are made are 1 x 10-2 to 5 x 10-3M (Broome, 1963; Mashburn et al., 1967).
As will be seen from Table I, this substrate concentration is saturating for both
TA-BLE I. Effect of Changes in Asparagine Concentration on Velocity of
Asparaginase Action
Reaction rates as percentage of
those obtained with 5-0 x 10-31A
asparagilne
Asparagine E. coli Agouti serum
concentration (m) asparaginase asparaginase
5)0 X 10 3
v 1000 100 0
10 X 10-4 1000- 68 0
2-5 x 10-5 64-2 23-0
1.0X 10 46-5 118
2 0 X 10-6 89 1.9
E. coli and agouti serum asparaginases. At 1 X 10-4 M, however, the agouti
serum enzyme is no longer saturated and acts with only 68 % of its maximal
velocity, while the E. coli enzyme maintains full activity. The divergence
between the behavior ofthe 2 enzymes becomes particularly marked at concentra-
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tions similar to those found physiologically. The average asparagine concentra-
tion in normal mouse blood is 2*5 x 10-5 moles/l. (Broome, 1968b), at this
concentration in vitro, the relative velocity of action of agouti serum asparaginase
is 23 %°; the E. coli enzyme is almost 3 times as active. At a lower concentration,
2 x 10-6 M, such as indeed occurs in vivo during asparaginase treatment (vide
infra) the activities of the 2 enzymes differ by a factor of 4-7.
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FIG. 1.-Reciprocal plot of reaction velocity and substrate concentration for agouti serum
asparaginase. Measurements were made by the use of 14C asparagine as described in the
section " Methods ". Substrate concentration (S) is expressed in molarity. Velocity (V)
is in moles asparagine hydrolyaed/ml. agouti serum/hr.
These observations may be explained by further kinetic findings. Reciprocal
plots of substrate concentration and velocity of enzyme action show in the case
of E. coli asparaginase a linear graph to an asparagine concentration of at least
4 X 10-6 M. A Km value of 1-25 x 10-5 M (standard deviation 0*18 in 4 deter-
minations) is found. But with agouti serum asparaginase the graph is linear
only for the higher asparagine concentrations (Fig. 1). If these results alone are
used an apparent Km of 4.11 x 10-5 (standard deviation 0-10 in 3 determinations)
is obtained. At lower concentrations, below approximately half the apparent
Km, the graph rises more steeply. This indicates an accelerated rate of fall in
reaction velocity. Such reaction plots have been observed previously for several
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enzymes (Dixon and Webb, 1964). In the present case the cause is unknown,
but it is possible that the asparaginase is allosteric, that is, for maximal activity
under the conditions now used, asparagine must simultaneously react with the
enzyme molecule at more than one site. Differences in the kinetic properties of
E. coli and agouti serum asparaginases are likely to be of importance in deter-
mining their biological effects. Certain other factors mayalso be significant.
-A ~~~0 A~~~~~~~~~~~~~~ -o0 A"
20z
<30- ,,,'_30
E
25- 9 ,40
o :
:1 ~~~~~~~~~~~~~~U)
W15 I 60
z ,,
C<,__, < * y
0 8 16 24 32 40 48
HOURS AFTER TREATMENT
FIG. 2. Blood asparagine levels in C3H mice injected with 150 units E. coli asparaginase
intravenously. In this and the experiment shown in Fig. 3 each point on the graph represents
the result from an individual mouse of a group injected together with the same enzyme
preparation.
A A * Asparaginase activity.
0--------0 Asparagine concentration.
Relationship between bloodasparagine levels and the rate ofclearance ofasparaginase
from the blood
When E. coli asparaginase is injected into normal mice in a tumor inhibitory
dose, a profound fall in the blood asparagine level occurs, as shown in Fig. 3,
to become undetectably low 2 hours later. Asparaginase is cleared rapidly from
the blood, in these experiments only 2 % of the initial activity is present at 12
hours. Nonetheless, the asparagine content of the blood is substantially reduced
at this time (to 2 1 n moles/ml.). At 24 hours and 36 hours no asparaginase is
detectable, yet blood levels of asparagine (8.0 and 11.5 n moles/ml.) are 28 %
and 53 % ofnormal. Related findings occur with agouti serum enzyme, which is
cleared from the blood much more slowly (Fig. 4). By 72 hours the enzyme has
almost completely disappeared from the blood, yet the blood asparagine level
remains at only 20 % ofnormal. These results show that the effect ofasparaginase
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continues after its removal from the blood. In the case ofthe E. coli enzyme they
may be explained by findings in the liver. This tissue normally possesses very
little asparaginase activity when measured at low substrate concentration
(1 X 1O-4M) while the E. coli enzyme is highly active under such conditions.
Twenty-four hours after treating mice with this enzyme, when only small amounts
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FIG. 3. Blood asparagine levels in C3H mice injected with 0*5 ml. agouti serum (170 units)
intraperitoneally
A A Asparaginase activity.
00 Asparagine concentration.
remain in the blood or in the spleen, assays show approximately 5 times more
asparaginase activity in the liver than in untreated controls (Table II). It is
likely that this represents sequestered E. coli enzyme, although activation or
induction ofliver enzyme has not been excluded. Whatever its nature, however,
the presence of this asparaginase could have a significant effect on the asparagine
content of the blood. The experiments described thus far have been performed
TABLE JI.-Asparaginase Activity in Tissues of Normal Mice 24 Hours
After Treatment with E. coli Asparaginase
Asparaginase
Treatment
(units)
None
300
Asparaginase activity*
r A
Blood Liver Spleen
0 4 89+2-23 (7) 0
2-48 + 0-78 (4) 21.58 + 2-84 (4) 1.5 ± 0.42 (2)
* n moles asparagine hydrolysed/hour/mg. or c.mm.
Figures in parentheses indicate the number of animals examined.
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in normal animals. In animals treated with asparaginase to inhibit tumor
growth an additional factor may augment the activity of enzyme against the
tumors.
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FIG. 4. Effect of the implantation of lymphoma 6C3HED cells on clearance ofE. coli aspara-
ginase from the blood. C3H/C57B1 F1 mice were injected intravenously with 550 units
asparaginase. Tumor-bearing animals were imnplanted with 1 million asparaginase-sensitive
lymphoma cells subcutaneously in each flank 4 days previously. In these, calculations of
enzyme half-life were made from blood levels at 10 and 20 hours.
Clearance ofasparaginase from the blood of tumor-bearing mice
Four days after implantation of asparaginase-sensitive cells of Lymphoma
6C3HED, and before palpable tumors have appeared, considerable changes are
found in the rate of clearance of E. coli asparaginase from the blood, as may be
seen in Fig. 5. Semi-logarithmic plots of the results show that the average half-
life ofthe enzyme in the blood ofnormal animals is 2-6 hours, while inthose implan-
ted with lymphoma cells this increases to 24*1 hours. Six days later, when tumors
of approximately 1-5 c. diameter have grown out, an essentially similar result is
found; the half-life of enzyme in 3 animals is 205 ± 1-1 hours. A delay in clear-
ance of enzyme is also found in animals bearing asparaginase-resistant 6C3HED
E
"-
z
CD
LU
C/)
z
0~
cr-
600ASPARAGINASES AS TUMOUR INHIBITORS
tumors of the same size, but the half-life in 3 animals, 10-8 4( 0.9 hours, is rather
less than in the case of sensitive tumors.
DISCUSSION
These results show three factors which may be responsible for the particularly
high tumor inhibitory effectiveness of the E. coli asparaginase in vivo. First,
the enzyme is highly active at the low asparagine concentrations found physiolo-
gically. Secondly, a high asparaginase activity is found in the liver after the
enzyme is removed from the blood, and blood asparagine levels remain low.
Thirdly, persistence ofenzyme in the blood is greatly prolonged after implantation
oflymphoma cells.
In vitro asparaginase-sensitive cells of Lymphoma 6C3HED do not survive
when the level of l-asparagine in the medium falls below 1 x 10-5 M (Broome,
1968b). The relative importance of the degree of depression below this level
for the development of cytotoxicity in sensitive tumor cells is not known. But
from kinetic studies the E. coli enzyme would be expected to cause a more pro-
found lowering of asparagine levels soon after injection than would the agouti
serum asparaginase. Furthermore, tumor inhibition is likely to be increased
by any factor which prolongs the depression ofblood asparagine. This, it appears,
results from raised asparaginase activity in the liver after E. coli enzyme is removed
from the blood. Implantation with 6C3HED lymphoma cells causes a marked
delay in clearance of E. coli asparaginase from the blood, and for these cells it is
probably of considerable importance in determining the effectiveness oftreatment.
The decreased rate of clearance of E. coli asparaginase from the blood of mice
implanted with 6C3HED cells does not appear to be directly due to the tumor
cells but rather to a transmissible agent carried by them. This has been shown
by making a homogenate of 6C3HED cells, filtering it through " Millipore "
discs of 0-22[t pore size, and injecting the filtrate intraperitoneally into 3 normal
mice. After 4 days the half-life of injected E. coli asparaginase was found to be
19-7 + 0 9 hours in these animals while in a control group values of 2-6 + 0.1 hours
were obtained. Next, 3 weeks later, the pooled blood plasma from each of the
2 groups of mice was injected into further normal animals. In 3 mice which
had received 0 5 ml. plasma from animals given tumor cell filtrates, the half-life
of asparaginase 4 days later was 21-3 + 1.1 hours, while in those given plasma
from controls it was 2 8 + 0 5 hours. It is possible that these results are caused
by the so-called " lactic dehydrogenase virus " or Riley agent which is carried
by 6C3HED cells (Riley et al., 1960; Plagemann et al., 1963). In the present
experiments we have found a rise from an average in 4 normal mice of 403 lactic
dehydrogenase units/ml. serum, assayed according to Wroblewski and LaDue
(1955), to an average of 2150 units/ml. 2 days after tumor cell implantation. The
rise in blood lactic dehydrogenase and other endogenous enzymes after infection
with the Riley agent has been shown to be associated with a decrease in the rate
at which these enzymes are removed from the blood (Riley et al., 1965; Notkins,
1965). The same mechanism may inhibit clearance of E. coli asparaginase.
Further observations confirming this conclusion have recently been obtained by
Riley and Campbell (1968, as yet unpublished).
Taken together, the results now presented emphasize the varied factors which
can influence the effectiveness of an asparaginase in bringing about tumor
inhibition.
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SUMMARY
Three factors are described which may be related to the greater effectiveness
of the inducible E. coli asparaginase in inhibiting mouse tumors than agouti
serum enzyme: first, a high avidity which enables the enzyme to retain strong
activity at concentrations of asparagine found physiologically; secondly, the
maintenance of low blood asparagine level for a period after removal of enzyme
from the blood, and thirdly, a considerable slowing in the rate of clearance of
enzyme from the blood of animals implanted with lymphoma cells.
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